You are here

CMI Working Paper 43

CMI critical illness diagnosis rates for accelerated business, 1999-2004

CMI Working Paper 43 presents claim diagnosis rates for accelerated critical illness insurance, on a 'lives' basis, using data for claims settled in 1999 to 2004

Four sets of rates are included in the paper:

  • males;
  • females;
  • non-smokers;
  • smokers.

The derivation of these diagnosis rates builds on our previous work. This had progressed to 'adjusted' results, which properly match claims to exposure, but do so in terms of settled claims, not diagnosed claims. The results in this paper are the first the CMI Critical Illness Committee has produced that relate to the date of diagnosis, when a critical illness claim is incurred.

The rates are by no means the only sets of rates that could have been derived from the data. Consequently the Committee is making available to member offices spreadsheets containing summarised data that will allow practitioners to experiment with alternative approaches.

The revised version of the working paper was released on 15 March 2010 and corrects some numbers in tables 3.16, C5 and C17.

Related documents

You might also like

Contact Details

If you have any questions about the CMI please email

info@cmilimited.co.uk

Filter or search events

Start date
E.g., 04/03/2021
End date
E.g., 04/03/2021

Events calendar

  • Finance in the Public Interest Series

    16 March 2021 - 23 March 2021

    Spaces available

    There is widening debate that many of our social, financial and regulatory institutions need to be rethought so that we can create more sustainable futures, particularly in light of the Covid-19 pandemic, the policy/macro-economic response to the pandemic and how it affects consumers, as well as the impending climate crisis. This multi-day series of three keynote webinars, individually presented by leading economist John Kay, Sir Paul Collier, Professor of Economics and Public Policy at the Blavatnik School of Government, Ashok Gupta, Chair at Mercer Ltd, and Nico Aspinall, Chief Investment Officer at B&CE, will open up discussion on these essential topics. The series will culminate in a panel session with Chief Economist of the Bank of England, Andy Haldane.

  • The price is righter

    16 March 2021

    Spaces available

    This webinar provides an overview of the state of the UK protection market, and how different insurers are using different levels of sophistication to price (such as using customer demand models). It considers how insurers have implemented these sophisticated pricing techniques, and the practical challenges they have faced.

  • Spaces available

    This discussion will revolve around the latest industry developments including and introduction to Part VII transfers and Schemes of Arrangement (process, parties involved and recent events), insights and lessons from recent with-profits transactions and restructurings (including Equitable Life and Pru-Rothesay), how firms can apply these learnings to future arrangements, and the outlook for future with-profits transactions and restructurings (including the impacts of Covid-19 and Brexit)

     

  • Spaces available

    What is stewardship and how has the landscape changed under the 2020 UK Stewardship Code? How does effective stewardship create long term value for beneficiaries and what roles do asset owners and asset managers play in active stewardship. This webinar will offer answers to these questions in a practical approach to stewardship reporting.

  • Spaces available

    Mis-estimation risk is a key element of demographic risk, and past work has focused on mis-estimation risk on a run-off basis.  However, this does not meet the requirements of regulatory regimes like Solvency II, which demands that capital requirements are set through the prism of a finite horizon like one year.  This paper presents a value-at-risk approach to mis-estimation risk suitable for Solvency II work.